CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 135 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $358,000 | -72.9% | 69,890 | -62.1% | 0.00% | -100.0% |
| Q2 2019 | $1,322,000 | -45.6% | 184,537 | +0.7% | 0.00% | -50.0% |
| Q1 2019 | $2,432,000 | +57.1% | 183,167 | -6.9% | 0.00% | 0.0% |
| Q4 2018 | $1,548,000 | -33.5% | 196,672 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $2,327,000 | -9.1% | 209,983 | +10.1% | 0.00% | 0.0% |
| Q2 2018 | $2,560,000 | +55.2% | 190,745 | +50.2% | 0.00% | 0.0% |
| Q1 2018 | $1,649,000 | +50.6% | 126,958 | +6.7% | 0.00% | +100.0% |
| Q4 2017 | $1,095,000 | – | 119,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |